|
| Press Releases |
|
 |
|
| Monday, November 17, 2025 |
|
|
JBM Healthcare Announces FY2026 Interim Results |
| JBM (Healthcare) Limited ('JBM Healthcare' or the 'Company', Stock Code: 2161, together with its subsidiaries, the 'Group'), a leading branded healthcare products marketer and distributor in Hong Kong, today announced its interim results for the six months ended 30 September 2025 ('FY2026 Interim' or the 'Reporting Period'). more info >> |
|
| Thursday, June 12, 2025 |
|
|
JBM Healthcare Delivers Strong FY2025 Annual Results, Net Profit Surged 51.2% to HK$197.3 Million |
| JBM (Healthcare) Limited ('JBM Healthcare' or the 'Company'; Stock Code: 2161, together with its subsidiaries, the 'Group'), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the annual results of the Group for the year ended 31 March 2025 ('FY2025' or the 'Reporting Period'). more info >> |
|
| Thursday, April 3, 2025 |
|
|
JBM Healthcare Completes Acquisition of 90% Interest in Tin Hee Tong |
| JBM (Healthcare) Limited ("JBM Healthcare"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, announced today that it has acquired a 90% stake in Tin Hee Tong Medicine Factory, Limited ("Tin Hee Tong",), at a total consideration of HK$171.0 million. more info >> |
|
| Tuesday, November 19, 2024 |
|
|
JBM Healthcare Announces FY2025 Interim Results |
| more info >> |
|
| Monday, November 4, 2024 |
|
|
JBM Healthcare Issues Positive Profit Alert |
| JBM (Healthcare) Limited ('JBM Healthcare' or the 'Company'; Stock Code: 2161, together with its subsidiaries, the 'Group'), a leading branded healthcare products marketer and distributor in Hong Kong, has today announced a positive profit alert. Based on a preliminary review of the unaudited consolidated management accounts of the Group for the six months ended 30 September 2024 and the information currently available to the board of directors of the Company, the Group expects to record an increase in the consolidated profit attributable to shareholders for the six months ended 30 September 2024 ('Consolidated Profit') by not less than 50% as compared to that for the same period last year. more info >> |
|
| Tuesday, June 18, 2024 |
|
|
JBM Healthcare Announces FY2024 Annual Results |
| JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the annual results of the Group for the year ended 31 March 2024 ("FY2024" or the "Reporting Period"). more info >> |
|
| Sunday, May 5, 2024 |
|
|
JBM Healthcare Issues Positive Profit Alert |
| JBM (Healthcare) Limited has announced a positive profit alert. Based on a preliminary review of the unaudited consolidated management accounts of the Group for the financial year ended 31 March 2024 and the information currently available to the board of directors of the Company, the Group is expected to record an increase in the consolidated profit attributable to shareholders for the year ended 31 March 2024 ("Consolidated Profit") by not less than 120% as compared to that for the same period last year. more info >> |
|
| Wednesday, November 22, 2023 |
|
|
JBM Healthcare Announces FY2024 Interim Results |
| JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the interim results of the Group for the six months ended 30 September 2023 (the "Reporting Period"). more info >> |
|
| Thursday, June 15, 2023 |
|
|
JBM Healthcare Announces FY2023 Annual Results |
| JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the annual results of the Group for the year ended 31 March 2023 ("FY2023" or the "Reporting Period"). more info >> |
|
| Friday, November 25, 2022 |
|
|
JBM Healthcare Announces FY2023 Interim Results |
| JBM (Healthcare) Limited ("JBM Healthcare" or the "Group"; Stock Code: 2161), a leading branded healthcare products marketer and distributor in Hong Kong, has announced today the interim results of the Group for the six months ended 30 September 2022 (the "Reporting Period"). more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
With Step-Out Drilling Continuing, Radisson Demonstrates Meaningful Resource Growth at O'Brien with an Updated Mineral Resource Estimate
Mar 2, 2026 19:59 HKT/SGT
|
|
|
Lincotrade Unveils Freehold Residential Project, The Shang Residence, in Kuala Lumpur, Malaysia
Mar 2, 2026 19:54 HKT/SGT
|
|
|
Focus Graphite Officially Commences Government-Supported Thermal Purification Project to Establish Dual-Use Graphite Production in Canada
Mar 2, 2026 18:29 HKT/SGT
|
|
|
The HK International Diamond, Gem & Pearl Show opens today; The HK International Jewellery Show starts Wednesday
Mar 2, 2026 18:20 HKT/SGT
|
|
|
MHI and SoftBank Corp. Collaborate to Adapt AI-RAN Network Architecture for Edge Data Centers
Mar 2, 2026 19:13 JST
|
|
|
Exito Media Concepts Announces the 32nd Edition of the Manufacturing IT Summit - Thailand 2026
Mar 2, 2026 17:00 HKT/SGT
|
|
|
DOCOMO and NEC Launch Japan's First Commercial 5G Core on AWS, Built with World's First AI-automated Network Construction Technology
Mar 2, 2026 16:34 JST
|
|
|
AI Safety Asia Advances Crisis Diplomacy and Evidence-Based AI Governance at India AI Impact Summit 2026
Mar 2, 2026 15:15 HKT/SGT
|
|
|
Fujitsu supports sustainable growth for retailers with data and AI through Uvance for Retail
Mar 2, 2026 11:55 JST
|
|
|
Quam Plus Financial Group and Dinosaur Financial Group Announce Strategic Partnership to Expand Cross-Border Capital Markets Access
Mar 2, 2026 10:42 HKT/SGT
|
|
|
WELIREG(R) (belzutifan) Plus LENVIMA(R) (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)
Mar 2, 2026 9:49 JST
|
|
|
The Tomorrow Company Launches With a Bold Mandate to Build the Infrastructure Layer of the AI-Native Financial Era.
Mar 2, 2026 08:06 HKT/SGT
|
|
|
CALB (3931.HK) Announced a Positive Profit Alert
Feb 28, 2026 11:43 HKT/SGT
|
|
|
Unisound U1-OCR: The First Industrial-Grade Document Intelligence Foundation Model, Ushering in the OCR 3.0 Era
Feb 28, 2026 09:00 HKT/SGT
|
|
|
NEC Strengthens Multi-Vendor Optical Network Solutions with New TIP-Certified Phoenix Hardware Lineup
Feb 27, 2026 18:50 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
